Chronic Depression
7
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
A Multiple Case Study of Schema Therapy for Difficult-to-treat Depression- DEPRE-ST*Case
Schema Therapy for Patients With Chronic Treatment Resistant Depression
Intensive Psychotherapy for Chronic Depression
Does Disciplined Personal Involvement Precede Change in CBASP?
Clinical Trials of Two Non-drug Treatments for Chronic Depression
Cognitive Behavioural Analysis System of Psychotherapy (CBASp) Versus Escitalopram in Chronic Depression
Getting Biased Treatment Study: How Psychotherapy and Antidepressants Change Brain Activity in Chronic Depression